L. Cookson

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.

J. Moon, J. Ritter, M. Pepys, 2015, The New England journal of medicine.

The Effect of Intravenous Infusion of Adenosine on Electrically Evoked Hyperalgesia in a Healthy Volunteer Model of Central Sensitization

M. Dusch, B. Chizh, M. Schmelz, 2004, Anesthesia and analgesia.

Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis

S. Zamuner, A. Berges, T. Sahota, 2015, CPT: pharmacometrics & systems pharmacology.

Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study

S. Solomon, R. Falk, G. V. van Dongen, 2022, BMC Cardiovascular Disorders.

Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis

J. Moon, J. Ritter, M. Pepys, 2018, Science Translational Medicine.

An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study

H. Millns, M. Lukas, L. Cookson, 2021, Orphanet Journal of Rare Diseases.

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Dose of Miridesap in Healthy Japanese Subjects

H. Itoh, Y. Doi, Chao Chen, 2019, Clinical pharmacology in drug development.